MHRA approves capivasertib for treatment of advanced breast cancer Capivasertib is an oral pill given with fulvestrant, a hormonal therapy, as an alternative treatment to endocrine-based regimens.…
Draft NICE guidance recommends ‘at-home’ pill for advance prostate cancer The National institute of Health and Care Excellence says up to 40,000 people in England could benefit from relugolix (Orgovyx; Accord).…
How AI is transforming drug discovery Pharmaceutical companies and start-ups are harnessing AI to improve speed and reduce costs at every stage of the drug discovery and development process.…
Lung cancer: screening, diagnosis and management An overview of the symptoms of suspected lung cancer, treatment strategies and current national screening programmes and pilots.…
Combination treatment before surgery improves melanoma survival rates, study results show The 12-month event-free survival rate for patients with macroscopic stage III node-positive melanoma was 83.7% with the combination treatment, compared with 57.2% for adjuvant therapy alone.…
Osimertinib treatment for advanced non-small cell lung cancer increases survival rates, study finds Patients treated with osimertinib had an average of 39.1 months of progression-free survival, compared with 5.6 months in those given placebo.…
Management of Waldenstrom’s macroglobulinaemia An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options.… Supported content
Why we are helping patients with lung cancer symptoms self-refer for a chest X-ray Pharmacies in Leeds are helping to diagnose lung cancer earlier by piloting a service that allows patients with red-flag symptoms to refer themselves to hospital for testing.…
More than 60 community pharmacies access cancer red-flag symptom card scheme Exclusive: The ‘Not normal for you?’ scheme enables pharmacists to identify patient behaviours that may signal cancer and refer patients for red-flag symptoms.…
Community pharmacy pilot to focus on spotting patients with early signs of lung cancer Four sites in England will focus on lung cancer as part of the ‘NHS supporting early diagnosis of cancer’ pilot service.…
